FastBuds seedbank #1 with 10786 diaries and a rating of Growdiaries 8.8/10 on GrowDiaries
Growdiaries 8.8/10 with 10786 diaries on GrowDiaries

Snoop Dogg Invests in a German Weed Startup, Betting on Imminent Legalization

21 February 2022
Germany seems to be on the verge of comprehensive cannabis legalization which presents a huge investment opportunity.
21 February 2022
2 min read
Snoop Dogg Invests in a German Weed Startup, Betting on Imminent Legalization

Last week, Snoop Dogg’s company, Casa Verde, took part in a Series B investment round for a startup that currently supplies medical cannabis to German pharmacies. The Frankfurt-based Cansativa received a check for $15 mln from the rap icon, the biggest he has written yet.

It’s not the first time Snoop Dogg betted on the bright future of the European cannabis industry. He also has a stake in AceCann, a medical marijuana producer in Portugal. However, Germany, once it goes through with the long-promised initiative to fully legalize cannabis, will create the biggest legal market in the world.

Betting on the Leader

At the moment, Germany only allows medical use of cannabis, but the country is unique in that it fully reimburses patients for their weed-based medicine. Probably, this is the reason why Germans consume 15 metric tons annually, and, if the trend continues, will account for more than half of Europe’s total use of medical marijuana by 2024.

There are even bolder estimates that Germany will consume 200 metric tons of recreational cannabis within two years of its proposed legalization. Any company positioned to become the leader of the industry is looking at monumental revenues. And Cansativa, Germany’s self-styled “Amazon of weed”, seems like the safest bet.

Snoop Dogg Invests in a German Weed Startup, Betting on Imminent Legalization: Brothers Sons, wearing suits and posing on a winding stairs

Brothers Sons, Cansativa's founders and CEOs.

Excellent Shape and Breathtaking Prospects

Founded by brothers Benedikt and Jakob Sons, Cansativa is a tech-based platform that makes it easy for pharmacies to purchase cannabis produced by international and domestic suppliers. Besides being the market’s leader in distributing imported weed, Cansativa has won an exclusive 4-year-long contract to supply locally grown marijuana.

Money raised in the latest investment round will go to the team of software engineers who need to make the B2B distribution platform ready for expansion. It should be easily scalable to include the recreational market. The owners expect this shouldn’t be an issue because regulations for dispensaries will be roughly the same as for pharmacies.

Cansativa’s more ambitios goal includes the whole of Europe. The company’s strategic placement in Frankfurt, which is one of the major transportation hubs in Europe, means excellen logistics and fast delivery of product all over the continent.